Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16234)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2019 (publication date) through Jul 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes 2019; 10(3): 154-168 [PMID: 30891151 DOI: 10.4239/wjd.v10.i3.154] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v10/i3/154.htm |
| Number | Citing Articles |
| 1 |
I. Liaqat, N. M. Ali, N. Arshad, S. Sajjad, F. Rashid, U. Hanif, C. Ara, M. Ulfat, S. Andleeb, U. F. Awan, A. Bibi, M. Mubin, S. Ali, H. M. Tahir, I. ul-Haq. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans. Brazilian Journal of Biology 2023; 83 doi: 10.1590/1519-6984.242818
|
| 2 |
Brian L. Furman, Mayuren Candasamy, Subrat Kumar Bhattamisra, Sajesh K. Veettil. Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies. Journal of Ethnopharmacology 2020; 247: 112264 doi: 10.1016/j.jep.2019.112264
|
| 3 |
Nazarii Kobyliak, Tetyana Falalyeyeva, Olena Tsyryuk, Majid Eslami, Dmytro Kyriienko, Tetyana Beregova, Liudmila Ostapchenko. New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study. Journal of Diabetes & Metabolic Disorders 2020; 19(1): 289 doi: 10.1007/s40200-020-00506-3
|
| 4 |
Maryana Savytska, Dmytro Kyriienko, Iuliia Komisarenko, Oleksandr Kovalchuk, Tetyana Falalyeyeva, Nazarii Kobyliak. Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Diabetes Therapy 2023; 14(11): 1915 doi: 10.1007/s13300-023-01474-6
|
| 5 |
Oleksandr Korotkyi, Yevheniia Kyriachenko, Nazarii Kobyliak, Tetyana Falalyeyeva, Liudmila Ostapchenko. Crosstalk between gut microbiota and osteoarthritis: A critical view. Journal of Functional Foods 2020; 68: 103904 doi: 10.1016/j.jff.2020.103904
|
| 6 |
Larissa Valadares Ramos, Teresa Helena Macedo da Costa, Sandra Fernandes Arruda. The effect of coffee consumption on glucose homeostasis and redox-inflammatory responses in high-fat diet-induced obese rats. The Journal of Nutritional Biochemistry 2022; 100: 108881 doi: 10.1016/j.jnutbio.2021.108881
|
| 7 |
Maryana Savytska, Dmytro Kyriienko, Ganna Zaychenko, Danylo Ostapchenko, Tetyana Falalyeyeva, Nazarii Kobyliak. Probiotic co-supplementation with absorbent smectite for pancreatic beta-cell function in type 2 diabetes: a secondary-data analysis of a randomized double-blind controlled trials. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1276642
|
| 8 |
Yue Xi, Peng-Fei Xu. Diabetes and gut microbiota. World Journal of Diabetes 2021; 12(10): 1693-1703 doi: 10.4239/wjd.v12.i10.1693
|
| 9 |
Yakubu Lawal. Gut dysbiosis. Journal of Current Research in Scientific Medicine 2022; 8(1): 12 doi: 10.4103/jcrsm.jcrsm_48_21
|
| 10 |
Luis Ricardo Balleza-Alejandri, Emiliano Peña-Durán, Alberto Beltrán-Ramírez, Africa Samantha Reynoso-Roa, Luis Daniel Sánchez-Abundis, Jesús Jonathan García-Galindo, Daniel Osmar Suárez-Rico. Decoding the Gut Microbiota–Gestational Diabetes Link: Insights from the Last Seven Years. Microorganisms 2024; 12(6): 1070 doi: 10.3390/microorganisms12061070
|
| 11 |
Shouyan Deng, Xiaolin Zhou, Jie Xu. Regulation of Cancer Immune Checkpoints. Advances in Experimental Medicine and Biology 2020; 1248: 431 doi: 10.1007/978-981-15-3266-5_18
|
| 12 |
А.Е. Абатуров, А.А. Никулина. Antibiotic Therapy as a Risk Factor of Obesity Development in Children. Педиатрия. Восточная Европа 2020; (2): 268 doi: 10.34883/PI.2020.8.2.013
|
| 13 |
Nazarii KOBYLIAK, Tetyana FALALYEYEVA, Yevheniia KYRIACHENKO, Yuliya TSEYSLYER, Oleksandr KOVALCHUK, Olena HADILIIA, Majid ESLAMI, Bahman YOUSEFI, Ludovico ABENAVOLI, Sharmila FAGOONEE, Rinaldo PELLICANO. Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. Minerva Endocrinology 2022; 47(2) doi: 10.23736/S2724-6507.22.03752-6
|
| 14 |
Thao T. B. Cao, Kun-Chang Wu, Jye-Lin Hsu, Chih-Shiang Chang, Chiahung Chou, Chen-Yuan Lin, Yu-Min Liao, Pei-Chun Lin, Liang-Yo Yang, Hsiang-Wen Lin. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.573891
|
| 15 |
Limin Wei, Bo Zeng, Bo Li, Wei Guo, Zhenqiang Mu, Yunong Gan, Yanhong Li. Hybridization alters red deer gut microbiome and metabolites. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1387957
|
| 16 |
Ramesh Pothuraju, Sanjib Chaudhary, Satyanarayana Rachagani, Sukhwinder Kaur, Hemant K. Roy, Michael Bouvet, Surinder K. Batra. Mucins, gut microbiota, and postbiotics role in colorectal cancer. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1974795
|
| 17 |
Yue Wang, Xianxian Jia, Bin Cong. Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1396031
|
| 18 |
Hanako Nakajima, Fumie Takewaki, Yoshitaka Hashimoto, Shizuo Kajiyama, Saori Majima, Hiroshi Okada, Takafumi Senmaru, Emi Ushigome, Naoko Nakanishi, Masahide Hamaguchi, Masahiro Yamazaki, Yoshiki Tanaka, Yousuke Oikawa, Shunji Nakajima, Hiroshi Ohno, Michiaki Fukui. The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study. Life 2020; 10(9): 195 doi: 10.3390/life10090195
|
| 19 |
Elena V. Pokrovskaya, Minara S. Shamkhalova, Marina V. Shestakova. The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2. Diabetes mellitus 2019; 22(3): 253 doi: 10.14341/DM10194
|
| 20 |
Oleksandr Korotkyi, Kateryna Dvorshchenko, Tetyana Falalyeyeva, Oksana Sulaieva, Nazarii Kobyliak, Ludovico Abenavoli, Sharmila Fagoonee, Rinaldo Pellicano, Liudmila Ostapchenko. Combined effects of probiotic and chondroprotector during osteoarthritis in rats. Panminerva Medica 2020; 62(2) doi: 10.23736/S0031-0808.20.03841-0
|
| 21 |
Manon Balvers, Bert-Jan H. van den Born, Evgeni Levin, Max Nieuwdorp. Impact drugs targeting cardiometabolic risk on the gut microbiota. Current Opinion in Lipidology 2021; 32(1): 38 doi: 10.1097/MOL.0000000000000727
|
| 22 |
Bharati Kadamb Patel, Kadamb Haribhai Patel, Shabbir M. Moochhala. Gut microbiota intervention strategies using active components from medicinal herbs to evaluate clinical efficacy of type 2 diabetes – A review. Clinical and Translational Discovery 2023; 3(1) doi: 10.1002/ctd2.170
|
| 23 |
Karine Marchioro Leal, Mariana Barcelos Rocha, Fernanda Venzon Varela, Luana Rodrigues, Priscila Viau Furtado, Fernanda Vieira Amorim da Costa, Álan Gomes Pöppl. Is Methylprednisolone Acetate-Related Insulin Resistance Preventable in Cats?. Topics in Companion Animal Medicine 2022; 49: 100648 doi: 10.1016/j.tcam.2022.100648
|
| 24 |
Jutatip Panaampon, Yubin Zhou, Charupong Saengboonmee. Metformin as a booster of cancer immunotherapy. International Immunopharmacology 2023; 121: 110528 doi: 10.1016/j.intimp.2023.110528
|
| 25 |
Luyao Zhang, Pai Wang, Juan Huang, Yanpeng Xing, F. Susan Wong, Jian Suo, Li Wen. Gut microbiota and therapy for obesity and type 2 diabetes. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1333778
|
| 26 |
Yanxia Chen, Mian Wang. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes. Drug Design, Development and Therapy 2021; : 4849 doi: 10.2147/DDDT.S334325
|
| 27 |
Meng Yang, Shambhunath Bose, Sookyoung Lim, JaeGu Seo, JooHyun Shin, Dokyung Lee, Won-Hyong Chung, Eun-Ji Song, Young-Do Nam, Hojun Kim. Beneficial Effects of Newly Isolated Akkermansia muciniphila Strains from the Human Gut on Obesity and Metabolic Dysregulation. Microorganisms 2020; 8(9): 1413 doi: 10.3390/microorganisms8091413
|
| 28 |
Pauke C. Schots, Kirsten M. Jansen, Jakub Mrazek, Alice M. Pedersen, Ragnar L. Olsen, Terje S. Larsen. Obesity-induced alterations in the gut microbiome in female mice fed a high-fat diet are antagonized by dietary supplementation with a novel, wax ester–rich, marine oil. Nutrition Research 2020; 83: 94 doi: 10.1016/j.nutres.2020.09.002
|
| 29 |
Ravi Kant, Lakshya Chandra, Vipin Verma, Priyanshu Nain, Diego Bello, Siddharth Patel, Subash Ala, Rashmi Chandra, Mc Anto Antony. Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus. World Journal of Methodology 2022; 12(4): 246-257 doi: 10.5662/wjm.v12.i4.246
|
| 30 |
Wei Mi, Zhiyong Hu, Shuying Zhao, Wei Wang, Wu Lian, Peng Lu, Tala Shi. Purple sweet potato anthocyanins normalize the blood glucose concentration and restore the gut microbiota in mice with type 2 diabetes mellitus. Heliyon 2024; 10(11): e31784 doi: 10.1016/j.heliyon.2024.e31784
|
| 31 |
Tetyana Falalyeyeva, Nazarii Kobyliak, Oleksandr Korotkyi, Tamara Meleshko, Oksana Sulaieva, Iryna Hryshchenko, Liudmyla Domylivska, Nadiya Boyko. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 101 doi: 10.1007/978-3-031-19564-8_5
|
| 32 |
Xintong Zhang, Ying Han, Wei Huang, Mingji Jin, Zhonggao Gao. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B 2021; 11(7): 1789 doi: 10.1016/j.apsb.2020.09.013
|
| 33 |
Sylwia Dzięgielewska-Gęsiak, Edyta Fatyga, Magdalena Piłot, Aleksander Wierzgoń, Małgorzata Muc-Wierzgoń. Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 3989 doi: 10.2147/DMSO.S400278
|
| 34 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Nazarii Kobyliak. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 275 doi: 10.1007/978-3-031-19564-8_10
|
| 35 |
Nicoleta Mihaela Mindrescu, Cristian Guja, Viorel Jinga, Sorina Ispas, Antoanela Curici, Rucsandra Elena Danciulescu Miulescu, Andreea Nelson Twakor, Anca Mihaela Pantea Stoian. SGLT-2 Inhibitors and Metabolic Outcomes: A Primary Data Study Exploring the Microbiota–Diabetes Connection. Metabolites 2025; 15(6): 411 doi: 10.3390/metabo15060411
|
| 36 |
Lan-lan Jiang, Xiao-hua Xu, Meng-hui Luo, Hui-ying Wang, Bo Ding, Reng-na Yan, Yun Hu, Jian-hua Ma. Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study. Diabetes Therapy 2021; 12(11): 2955 doi: 10.1007/s13300-021-01151-6
|
| 37 |
Minchun Zhang, Rilu Feng, Mei Yang, Cheng Qian, Zheng Wang, Wei Liu, Jing Ma. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Research & Care 2019; 7(1): e000717 doi: 10.1136/bmjdrc-2019-000717
|
| 38 |
Nazarii Kobyliak, Tetyana Falalyeyeva, Galyna Mykhalchyshyn, Nataliia Molochek, Olexii Savchuk, Dmytro Kyriienko, Iuliia Komisarenko. Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A randomised controlled trial. Obesity Medicine 2020; 19: 100248 doi: 10.1016/j.obmed.2020.100248
|
| 39 |
Samet Izgi, Ibrahim F. Sengul, Engin Şahin, Mehmet Serdar Koca, Fatma Cebeci, Hakan Kandemir. Synthesis of 7-azaindole based carbohydrazides and 1,3,4-oxadiazoles; Antioxidant activity, α-glucosidase inhibition properties and docking study. Journal of Molecular Structure 2022; 1247: 131343 doi: 10.1016/j.molstruc.2021.131343
|
| 40 |
Eunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, Sang Chun Ji, Joo‐Youn Cho, Kyung‐Sang Yu, Jae‐Yong Chung. Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects. Clinical and Translational Science 2021; 14(5): 1955 doi: 10.1111/cts.13051
|
| 41 |
Young Sup Woo, Hyun Kook Lim, Sheng-Min Wang, Won-Myong Bahk. Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review. International Journal of Molecular Sciences 2020; 21(18): 6969 doi: 10.3390/ijms21186969
|
| 42 |
Mahmoud Aludwan, Nazarii Kobyliak, Ludovico Abenavoli, Dmytro Kyriienko, Sharmila Fagoonee, Rinaldo Pellicano, Iuliia Komisarenko. Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes. Minerva Endocrinologica 2020; 45(3) doi: 10.23736/S0391-1977.20.03161-2
|
| 43 |
Xiaohong Niu, Panpan Lu, Linqing Huang, Yan Sun, Miaomiao Jin, Jing Liu, Xing Li. The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes. International Microbiology 2023; 27(1): 265 doi: 10.1007/s10123-023-00380-y
|
| 44 |
Asimina Koulouridi, Ippokratis Messaritakis, Nikolaos Gouvas, John Tsiaoussis, John Souglakos. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer. Cancers 2020; 13(1): 43 doi: 10.3390/cancers13010043
|
| 45 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Luigi Boccuto, Emidio Scarpellini, Nazarii Kobyliak, Ludovico Abenavoli. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina 2022; 58(1): 84 doi: 10.3390/medicina58010084
|
| 46 |
Rajesh P Shastry, P D Rekha. Bacterial cross talk with gut microbiome and its implications: a short review. Folia Microbiologica 2021; 66(1): 15 doi: 10.1007/s12223-020-00821-5
|
| 47 |
Bocun Li, Jing Liu, Chuan He, Zhou Deng, Xiaohong Zhou, Rui Peng. Unveiling the Therapeutic Potential of Berberine in Rheumatoid Arthritis: A Comprehensive Study of Network Pharmacology, Metabolomics, and Intestinal Flora. Journal of Inflammation Research 2024; : 10849 doi: 10.2147/JIR.S493892
|
| 48 |
Alka Hasani, Saba Ebrahimzadeh, Fatemeh Hemmati, Aytak Khabbaz, Akbar Hasani, Pourya Gholizadeh. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis.
Journal of Medical Microbiology
2021; 70(10) doi: 10.1099/jmm.0.001435
|
| 49 |
Hafiz Muhammad Adnan Tariq, Nayyab Younas Khan, Haseeb Manzoor, Masood Ur Rehman Kayani. Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics. Discover Medicine 2025; 2(1) doi: 10.1007/s44337-025-00241-9
|
| 50 |
Sara Verdura, Elisabet Cuyàs, Begoña Martin-Castillo, Javier A. Menendez. Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy. OncoImmunology 2019; 8(10): e1633235 doi: 10.1080/2162402X.2019.1633235
|
| 51 |
Tetyana Falalyeyeva, Natalia Chornenka, Liubov Cherkasova, Olena Tsyryuk, Nataliia Molchek, Oleksandr Kovalchuk, Yevheniia Kyriachenko, Liudmila Ostapchenko, Nazarii Kobyliak. Comprehensive Gut Microbiota. 2022; : 201 doi: 10.1016/B978-0-12-819265-8.00030-9
|
| 52 |
Smriti Bansal, Archana Tomer, Purnima Jain. Natural Product-Inspired Vanadium Pentoxide Nanoparticles Unlock Diabetic Therapeutic Potential: In Vitro and In Silico Evaluation. ACS Applied Bio Materials 2025; 8(3): 2027 doi: 10.1021/acsabm.4c01534
|
| 53 |
Julie Kristine Knudsen, Peter Leutscher, Suzette Sørensen. Gut Microbiota in Bone Health and Diabetes. Current Osteoporosis Reports 2021; 19(4): 462 doi: 10.1007/s11914-020-00629-9
|
| 54 |
Katarzyna Śliżewska, Michał Włodarczyk, Martyna Sobczak, Renata Barczyńska, Janusz Kapuśniak, Piotr Socha, Aldona Wierzbicka-Rucińska, Aneta Kotowska. Comparison of the Activity of Fecal Enzymes and Concentration of SCFA in Healthy and Overweight Children. Nutrients 2023; 15(4): 987 doi: 10.3390/nu15040987
|
| 55 |
Dong Keon Oh, Hyun Sik Na, Joo Yeon Jhun, Jeong Su Lee, In Gyu Um, Seung Yoon Lee, Myeong Soo Park, Mi-La Cho, Sung-Hwan Park, Win Min Oo. Bifidobacterium longum BORI inhibits pain behavior and chondrocyte death, and attenuates osteoarthritis progression. PLOS ONE 2023; 18(6): e0286456 doi: 10.1371/journal.pone.0286456
|
| 56 |
O.H. Korotkyi, T.V. Luhovska, T.M. Serhiychuk, K.O. Dvorshchenko, T.M. Falalyeyeva, L.I. Ostapchenko. The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration of Chondroitin Sulfate and Probiotic. Mikrobiolohichnyi Zhurnal 2020; 82(6): 64 doi: 10.15407/microbiolj82.06.064
|
| 57 |
JooYeon Jhun, Keun-Hyung Cho, Dong-Hwan Lee, Ji Ye Kwon, Jin Seok Woo, Jiyoung Kim, Hyun Sik Na, Sung-Hwan Park, Seok Jung Kim, Mi-La Cho. Oral Administration of Lactobacillus rhamnosus Ameliorates the Progression of Osteoarthritis by Inhibiting Joint Pain and Inflammation. Cells 2021; 10(5): 1057 doi: 10.3390/cells10051057
|
| 58 |
Thiquynhnga Nguyen, Min Gong, Song Wen, Xinlu Yuan, Chaoxun Wang, Jianlan Jin, Ligang Zhou. The Mechanism of Metabolic Influences on the Endogenous GLP-1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus. Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/4727390
|
| 59 |
Paul J. McMurdie, Magdalena K. Stoeva, Nicholas Justice, Madeleine Nemchek, Christian M. K. Sieber, Surabhi Tyagi, Jessica Gines, Connor T. Skennerton, Michael Souza, Orville Kolterman, John Eid. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes. BMC Microbiology 2022; 22(1) doi: 10.1186/s12866-021-02415-8
|
| 60 |
Daniela Maria Tanase, Alina Mihaela Leustean, Evelina Maria Gosav. Gut Microbiota in Neurologic and Visceral Diseases. 2021; : 159 doi: 10.1016/B978-0-12-821039-0.00005-8
|
| 61 |
Raymond Chang. Drug Repurposing - Molecular Aspects and Therapeutic Applications. 2022; doi: 10.5772/intechopen.96101
|
| 62 |
Tanuka Das, Tandrani Das, Goutam Ghosh. Prebiotics, Probiotics and Nutraceuticals. 2022; : 155 doi: 10.1007/978-981-16-8990-1_9
|
| 63 |
Eva Alvarez-Vieites, Arora López-Santamarina, José M. Miranda, Alicia del Carmen Mondragón, Alexandre Lamas, Alejandra Cardelle-Cobas, Carolina Nebot, Carlos M. Franco, Alberto Cepeda. Influence of the Intestinal Microbiota on Diabetes Management. Current Pharmaceutical Biotechnology 2020; 21(15): 1603 doi: 10.2174/1389201021666200514220950
|
| 64 |
Yangxin Li, Chuan Liu, Jie Luo, Yong Zeng, Xianli Meng, Shaohui Wang, Yi Zhang. Ershiwuwei Lvxue Pill alleviates rheumatoid arthritis by different pathways and produces changes in the gut microbiota. Phytomedicine 2022; 107: 154462 doi: 10.1016/j.phymed.2022.154462
|
| 65 |
Rosa Elvira Alarcón Yempén, Raphaelly Venzel, Maria Clara Paulino Campos, Larissa Pessoa de Oliveira, Rodrigo Vasquez Dan Lins, André Moreira Pessoni, Gustavo Bernardes Fanaro, Anderson de Oliveira Souza, Karin da Costa Calaza, José Luiz de Brito Alves, Marinaldo Pacífico Cavalcanti-Neto. Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?. Life Sciences 2021; 286: 120060 doi: 10.1016/j.lfs.2021.120060
|